Scarica l'app Stockscreener
1.21
1.63%
-0.02
Dopo l'orario di chiusura:
1.22
0.01
+0.83%
Dermata Therapeutics Inc Borsa (DRMA) Ultime notizie
Dermata Therapeutics Stock Price Forecast. Should You Buy DRMA? - StockInvest.us
Dermata Therapeutics Inc. Warrant (DRMAW) Peer Comparison – Compare with Others - valueresearchonline.com
Dermata Therapeutics Inc. Warrant (DRMAW) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
Dermata Therapeutics (DRMA) Drops 8.22% to $1.34 as Selling Pressure Drags Micro-Cap Biotech LowerMAMA Signal - vinanet.vn
Dermata launches first direct-to-consumer skincare product By Investing.com - Investing.com UK
Dermata launches first direct-to-consumer skincare product - Investing.com India
Dermata (DRMA) Latest Quarter: Reported EPS Misses Expectations in the Current Update; Closing Move: Shares Move 2.90% Up for the Current SessionAnnual Report - vinanet.vn
Dermata Therapeutics (NASDAQ:DRMA) Commercial Strategy Gains Attention - Kalkine Media
Dermata opens preorders for Tome skincare product - Investing.com
Dermata opens preorders for Tome skincare product By Investing.com - Investing.com Canada
Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch - newswire.com
Dermata (DRMA) Results Check: EPS Comes in Below Forecast in the Latest Reading; Market Response: Shares Move 2.80% Up for the Current SessionStrong Earnings Momentum - vinanet.vn
Dermata (NASDAQ: DRMA) ends Nasdaq listing for warrants - Stock Titan
Dermata Therapeutics raises $3.4 million in private placement - Investing.com
Dermata Therapeutics Announces Private Placement to Fund DTC Pivot - TipRanks
Form 8K Dermata Therapeutics Inc For: 17 August By Investing.com - Investing.com South Africa
Dermata Therapeutics raises $3.4 million in private placement By Investing.com - Investing.com Canada
Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - ACCESS Newswire
Dermata Therapeutics Raises $3.2 Million in Private Placement; Investors Get Resale Rights - TradingView
Dermata Therapeutics, Inc. announced that it expects to receive $3.347307 million in funding - marketscreener.com
DRMA Q2 2026 Earnings: Wider-Than-Expected Loss Despite 13.8% Share Price AdvanceGross Profit Margin - vinanet.vn
Why CoreWeave Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - Sahm
DRMA|Dermata Therapeutics Inc|Price:1.370|Chg%:+0.290 - TradingKey
Dermata Therapeutics Stock Surges 27% Pre-Market: Why is it Moving? - webull.com
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Unusual volume stocks are being observed in Wednesday's session. - ChartMill
The market is filled with gapping stocks in Wednesday's session. - ChartMill
DRMA Stock In Focus As Dermata Pivots To Direct-To-Consumer Skincare - timothysykes.com
DRMA Stock Draws Traders As Dermata Pivots To Skincare - StocksToTrade
Went from a daytrader to a swing trader just like that... - Moomoo
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
DRMA Stock Draws Traders As Dermata Pivots To Skincare Launch - StocksToTrade
DERMATA THERAPEUTICS ($DRMA) Releases Q2 2026 Earnings, Stock Rises - Quiver Quantitative
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Dermata Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Trending Stocks Today | Dermata Therapeutics Soars 35.18% Post-Market - Moomoo
DRMA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Dermata Therapeutics (DRMA) faces going concern warning amid higher losses and cash burn - Stock Titan
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026 - ACCESS Newswire
Dermata's Tome Skincare Product Is Designed for Once-Weekly Use - Stock Titan
Dermata Therapeutics Inc expected to post a loss of 55 cents a shareEarnings Preview - TradingView
Dermata Therapeutics Inc (NASDAQ: DRMA) Share Price, DRMA Stock News, DRMA Share Price & Updates - kalkine.com.au
Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment - webull.com
Dermata Therapeutics Launches Tome Foundational Skincare Line - TipRanks
Dermata to launch first consumer skincare product Aug. 25 - Investing.com
Dermata to launch first consumer skincare product Aug. 25 By Investing.com - Investing.com South Africa
Dermata’s First Consumer Brand Wants to Function as ‘Microneedling Lite’ - WWD
DRMA Q1 2026 Earnings: Narrower-than-Expected Loss Delivers 11.21% EPS Surprise as Pipeline Takes Center StageEPS Estimate Trend - vinanet.vn
DRMA Q1 2026 Earnings: Narrower Loss of $0.48 per Share Beats Estimates as Clinical-Stage Biotech Remains Pre-RevenueGuidance Update - vinanet.vn
Dermata Therapeutics, Inc. Revenue Breakdown – NASDAQ:DRMA - TradingView
Dermata Therapeutics Inc (DRMA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
DRMA|Dermata Therapeutics Inc|Price:1.290|Chg%:-0.030 - TradingKey
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):